Market Overview:
The global genito-urinary market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of genito-urinary diseases, rising geriatric population, and technological advancements in the field of genito-urinary treatment. The global genito-urinary market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into OTC drugs and Rx drugs. The Rx drugs segment is further subsegmented into antibiotics, antivirals & antifungals, urological products (including prostate cancer treatments), and other Rx drugs. On the basis of application, the market is divided into hospitals pharmacies & clinics), drug stores (community pharmacies), and other applications (including online pharmacies). Geographically, it has been analyzed across North America (U.S., Canada., Mexico.), Latin America (Brazil Argentina.), Europe(Germany France Italy Spain U K.), Asia Pacific(Japan China India Australia South Korea Taiwan Thailand Malaysia Indonesia Philippines Vietnam Rest Of APAC) MEA.(South Africa Saudi Arabia UAE Qatar Kuwait Oman Bahrain Jordan Lebanon Syria Tunisia Algeria Egypt Morocco Nigeria Kenya South Africa Rest Of MEA).
Product Definition:
Treatment for Genito-Urinary is the medical care and treatment of diseases and disorders of the male and female urinary tract system. It is important because it helps maintain good health and prevent problems from occurring.
OTC:
OTC stands for Over-the-Counter and is a category of medicines that can be used for the treatment of various conditions without a prescription. OTC drugs are sold in small quantities, usually in multi-ounce containers with dosing information on the label. They do not require any prescription but may have restrictions on their distribution depending upon the licensing laws applicable in different countries.
Rx Drugs:
Rx drugs are the ones that are purchased from pharmacies, drug stores or online stores and used to treat a particular disease or medical condition. The global genito-urinary market is one of the most lucrative markets for Rx drugs as it comprises a large number of people suffering from various diseases such as urinary retention, cystitis, benign prostatic hyperplasia among others.
Application Insights:
The other application segment held the largest share of more than 70.0% in 2017. The other applications include emergency treatment, travel medicine, and others such as social care and primary healthcare. Genito-urinary diseases are one of the major health issues globally due to increasing population along with changing lifestyle habits that encourage risk taking and sedentary life styles that promote obesity & diabetes which further leads to genito-urinary disorders.
Drug stores are expected to be fastest growing market for genito-urinary drugs at a CAGR of XX% from 2018 to 2030 owing to factors such as availability of online pharmacies which sell OTC medicines with less professional help and expertise required by patients regarding proper dosage etc.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising incidence of BPH are some factors responsible for its growth. According to a study published in NCBI, Incidence rates of Benign Prostatic Hyperplasia (BPH) were found to be highest among North American countries followed by Europe.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure and economic development in emerging markets such as India and China.
Growth Factors:
- Increasing incidence of genito-urinary diseases: The global incidence of genito-urinary diseases is increasing rapidly. This is primarily due to the changing lifestyles and dietary habits of people across the world. This is expected to drive the demand for treatment for genito-urinary diseases in the coming years.
- Growing awareness about available treatments: There has been a significant increase in awareness about various treatments for genito-urinary diseases in recent years. This has led to an increase in demand for such treatments, especially among patients who are suffering from these conditions.
- Technological advancements: The field of treatment for genito-urinary diseases is constantly evolving with new technological advancements being made every day. This has led to better and more effective treatment options becoming available, which is driving growth in this market segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
Treatment for Genito-Urinary Market Research Report
By Type
OTC, Rx Drugs
By Application
Hospital, Drugs Store, Other
By Companies
Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, Allergan, GSK, Otsuka Pharmaceutical, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Treatment for Genito-Urinary Market Report Segments:
The global Treatment for Genito-Urinary market is segmented on the basis of:
Types
OTC, Rx Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Daiichi Sankyo Company
- Pfizer
- Bayer
- Astellas Pharma
- Allergan
- GSK
- Otsuka Pharmaceutical
- Sanofi
Highlights of The Treatment for Genito-Urinary Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OTC
- Rx Drugs
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Treatment for Genito-Urinary Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for genito-urinary problems will vary depending on the individual's symptoms and medical history. However, some common treatments for genito-urinary issues include antibiotics and antifungal medications, surgery (such as a urethral catheterization), and physical therapy.
Some of the major companies in the treatment for genito-urinary market are Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, Allergan, GSK, Otsuka Pharmaceutical, Sanofi.
The treatment for genito-urinary market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Treatment for Genito-Urinary Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Treatment for Genito-Urinary Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Treatment for Genito-Urinary Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Treatment for Genito-Urinary Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Treatment for Genito-Urinary Market Size & Forecast, 2020-2028
4.5.1 Treatment for Genito-Urinary Market Size and Y-o-Y Growth
4.5.2 Treatment for Genito-Urinary Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 OTC
5.2.2 Rx Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Treatment for Genito-Urinary Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Treatment for Genito-Urinary Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 OTC
9.6.2 Rx Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 OTC
10.6.2 Rx Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 OTC
11.6.2 Rx Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 OTC
12.6.2 Rx Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 OTC
13.6.2 Rx Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Treatment for Genito-Urinary Market: Competitive Dashboard
14.2 Global Treatment for Genito-Urinary Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Daiichi Sankyo Company
14.3.2 Pfizer
14.3.3 Bayer
14.3.4 Astellas Pharma
14.3.5 Allergan
14.3.6 GSK
14.3.7 Otsuka Pharmaceutical
14.3.8 Sanofi
